Corcept Therapeutics Inc
NASDAQ:CORT
Wall Street
Price Targets
CORT Price Targets Summary
Corcept Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
CORT
is 43.58 USD
with a low forecast of 35.35 USD and a high forecast of 64.05 USD.
CORT Last Price Targets
Corcept Therapeutics Inc
The latest public price target was made on May 2, 2024 by
Swayampakula Ramakanth
from
H.C. Wainwright
,
who expects
CORT
stock to
rise by 60%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Swayampakula Ramakanth
H.C. Wainwright
|
40
USD
Upside 60% |
1 day ago
May 2, 2024
|
Corcept Therapeutics (CORT) PT Raised to $40 at H.C. Wainwright
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CORT's stock price target?
Price Target
43.58
USD
According to Wall Street analysts, the average 1-year price target for
CORT
is 43.58 USD
with a low forecast of 35.35 USD and a high forecast of 64.05 USD.
What is Corcept Therapeutics Inc's Revenue forecast?
Projected CAGR
18%
For the last 8 years the
compound annual growth rate for
Corcept Therapeutics Inc's revenue is
33%.
The projected
CAGR
for the next 3 years is
18%.
What is Corcept Therapeutics Inc's Operating Income forecast?
Projected CAGR
39%
The
compound annual growth rate
of Corcept Therapeutics Inc's operating income for the next 3 years is
39%.
What is Corcept Therapeutics Inc's Net Income forecast?
Projected CAGR
27%
The
compound annual growth rate
of Corcept Therapeutics Inc's net income for the next 3 years is
27%.
You don't have any saved screeners yet
